Visioneering
Alpharetta
About Visioneering
Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences. VTI was founded by Dr. Richard A. Griffin, an optometrist, optical engineer and aerospace engineer who has spent 20 years developing VTI’s optical solutions. From Dr. Griffin's design, VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories. VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $14.0M
- Funding stage: IPO
- Last round: Series B (Aug 2016)
- Ticker: asx:VTI
- Website: vtivision.com
- Phone: (844)884-5367
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/visioneering-2213595 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.